Michel Detheux, CEO Iteos Therapeutics :
"VIVES has played a unique dual role as incubator and spin off investor during the inception of iTeos not only to shape the equity story, but also to connect the founders with key stakeholders, additional investors and experts in biotechnology in parallel to bridging iTeos with the academic experts of UCLouvain"
